Log in
Enquire now
IDbyDNA

IDbyDNA

A company that develops next-generation sequencing (NGS) metagenomics company developing infectious disease tests. It was founded in 2014 and is located in Salt Late City, Utah.

OverviewStructured DataIssuesContributors

Contents

idbydna.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Engineering
Engineering
Bioinformatics
Bioinformatics
Biomedical engineering
Biomedical engineering
Genomics
Genomics
DNA sequencing
DNA sequencing
Genetics
Genetics
Technology
Technology
...
Location
Salt Lake City
Salt Lake City
San Francisco
San Francisco
B2X
B2B
B2B
CEO
Guochun Liao
Guochun Liao
Founder
‌
Mark Yandell
Guochun Liao
Guochun Liao
Legal Name
IDbyDNA Inc.
Full Address
675 Arapeen Drive, Suite 301 Salt Lake City, UT 84108
Investors
Genesys Capital
Genesys Capital
ARTIS Ventures
ARTIS Ventures
Founded Date
2014
Total Funding Amount (USD)
29,000,000
Latest Funding Round Date
January 29, 2020
Glassdoor ID
1416299
Latest Funding Type
Series B
Series B
Country
United States
United States

Other attributes

Company Operating Status
Active

IDbyDNA is a Salt Lake City-based biotechnology company with a focus on metagenomics technology. The company has developed technologies and a platform that profile micro-organisms and pathogens simultaneously in high volumes. The company has a solution for recognizing particles, pathogens, and other micro-organisms, and they called it Explify Respiratory. The solution applies DNA and RNA sequencing to detect and identify bacterial, viral, fungal, and parasitic pathogens by their unique genome sequences. The company uses this technology to identify common and rare pathogens, especially ones difficult to culture, new strains, and complex co-infections.

COVID-19

Since the outbreak of COVID-19, IDbyDNA has made available their Explify Respiratory test which can detect 2019-nCoV as well as over 900 other pathogens. It has also partnered with Illumina to co-market the technology as well as develop it further for more advanced COVID-19 surveillance methods. IDbyDNA is in contact with and cooperates with public health agencies to ensure a coordinated response to suspected or confirmed cases of COVID-19 in patients. The test is able to adapt to emerging and changing pathogens. Their technology and test is a validated Laboratory Developed Test.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

D1 16:15 T1-Charles Chiu, UCSF; Robert Schlaberg, IDbyDNA; Heike Sichtig FDA; and Mickey Kertesz, Karius

https://vimeo.com/203982777

February 14, 2017

IDbyDNA to Advance Platform, Now Including Novel Coronavirus, Expand Commercial Operations

Alex Philippidis

https://www.genengnews.com/news/idbydna-to-advance-platform-now-including-novel-coronavirus-expand-commercial-operations/

Web

January 29, 2020

Illumina taps IDbyDNA for infectious disease sequencing co-marketing initiative

Conor Hale

https://www.fiercebiotech.com/medtech/illumina-taps-idbydna-for-infectious-disease-sequencing-initiative

Web

March 18, 2020

Novel Wuhan Coronavirus Detectable with IDbyDNA Explify Respiratory Test

https://www.businesswire.com/news/home/20200128005828/en/Wuhan-Coronavirus-Detectable-IDbyDNA-Explify-Respiratory-Test

Web

January 28, 2020

References

Find more companies like IDbyDNA

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.